Literature DB >> 203546

Two E-rosette-forming lymphoid cell lines.

S Morikawa, E Tatsumi, M Baba, T Harada, K Yasuhira.   

Abstract

Two E-rosette (spontaneous rosette with sheep red blood cells)-forming lymphoid cell lines were established. One (HPB-ALL) was derived from a young male Japanese patient with acute lymphoblastic leukemia (ALL), and the other (HPB-MLT) was from a 62-year-old female Japanese patient with a leukemic T-lymphoid malignancy. Formation of E rosettes, absence of any immunoglobulin determinants, absence of EBNA (Epstein-Barr virus associated nuclear antigen) and very limited stimulating ability in mixed lymphocyte culture, were characteristics mostly identical with those of so far established T-cell-derived lymphoid cell lines, MOLT, CCRF-CEM, CCRF-HS-B2, RPMI-8402 and JM. Only HPB-MLT, however, has been derived from an aged patient with T-lymphoid malignancy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 203546     DOI: 10.1002/ijc.2910210207

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  37 in total

1.  Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor.

Authors:  K M Haan; W W Kwok; R Longnecker; P Speck
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Expression of MHC class II in T cells is associated with increased HIV-1 expression.

Authors:  M Saifuddin; G T Spear; C Chang; K A Roebuck
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells.

Authors:  Y W Zhang; S C Bae; G Huang; Y X Fu; J Lu; M Y Ahn; Y Kanno; T Kanno; Y Ito
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

4.  Expression of T3 in association with a molecule distinct from the T-cell antigen receptor heterodimer.

Authors:  A Weiss; M Newton; D Crommie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Anti-Kaposi's sarcoma and antiangiogenic activities of sulfated dextrins.

Authors:  M Thornton; L Barkley; J C Mason; S Shaunak
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

6.  Expression of Pax5 gene in human haematopoietic cells and tissues: comparison with immunodeficient donors.

Authors:  H Kaneko; T Ariyasu; R Inoue; T Fukao; K Kasahara; T Teramoto; E Matsui; S Hayakawa; N Kondo
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

7.  IgG heavy chain allotype (Gm), a genetic marker for human chromosome 14q32, and haematopoietic malignancies.

Authors:  Y Nakao; H Matsumoto; K Tsuji; T Miyazaki; T Masaoka; S Nakayama; K Kinoshita; T Shingami; T Matsui; T Fujita
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

8.  A novel reduced immunogenicity bispecific targeted toxin simultaneously recognizing human epidermal growth factor and interleukin-4 receptors in a mouse model of metastatic breast carcinoma.

Authors:  Seunguk Oh; Brad J Stish; Deepali Sachdev; Hua Chen; Arkadiusz Z Dudek; Daniel A Vallera
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

9.  Genomic approaches uncover increasing complexities in the regulatory landscape at the human SCL (TAL1) locus.

Authors:  Pawandeep Dhami; Alexander W Bruce; Johanna H Jim; Shane C Dillon; Amanda Hall; Jonathan L Cooper; Nicolas Bonhoure; Kelly Chiang; Peter D Ellis; Cordelia Langford; Robert M Andrews; David Vetrie
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

10.  Biological and biochemical studies of African green monkey lymphotropic papovavirus.

Authors:  K K Takemoto; A Furuno; K Kato; K Yoshiike
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.